APR 13, 2020 10:48 PM PDT

Experimental Drug Prevents Cancer Relapse

WRITTEN BY: Nouran Amin

One of the main challenges of cancer treatments is preventing the cancer from returning again—in essence stopping relapse. As part of a study, researchers found that a well-tolerated drug prevents relapse in mouse models.

Findings were published in Nature Communications and shows that the drug, Quisinostat, can block stop tumor re-growth and stop expansion of surviving human cancer cells in culture. Quisinostat works by elevating the protein levels of histone H1.0 within the tumor cells which prevents these cells from replicating.

"This drug works by disabling the cells that fuel long-term cancer growth and drive disease relapse. These early findings even suggest it may be more effective than commonly used drugs that inhibit tumor growth,” says Cristina Morales Torres, lead author and Principal Laboratory Research Scientist in the Cancer Epigenetics Laboratory at the Francis Crick Institute. "Further research is still needed to confirm whether this drug could prevent cancer coming back in people or if it could be used to control someone's disease long term."

When researchers examined the drug in mice, they found that it halted growth significantly. They tested it further on cancer cells taken from the breast, lung, and pancreases—results suggested that Quisinostat trapped the cancer cells in a non-dividing state.

Learn more about cancer biology:

Paola Scaffidi, co-author and Group Leader of the Cancer Epigenetics Laboratory at the Crick and Professorial Research Associate at the UCL Cancer Institute, says: "Just like stem cells that continuously produce progeny to keep our normal tissues healthy, cancer cells grow, divide and use energy. That's why finding a potential drug that halts tumour growth without hurting normal cells has been a challenge. Excitingly, with Quisinostat, we've seen no harm to healthy stem cells in our initial studies."

Source: Science Daily

 

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 15, 2022
Drug Discovery & Development
Low-dose Lithium Has Anti-aging Effects on Liver
APR 15, 2022
Low-dose Lithium Has Anti-aging Effects on Liver
Low-dose lithium can block an enzyme linked to cellular aging and functional decline in the kidneys. The corresponding s ...
APR 25, 2022
Health & Medicine
Sex differences in association between cannabis use and diabetes
APR 25, 2022
Sex differences in association between cannabis use and diabetes
A preprint published in Cannabis Cannabinoid Research examined the association between cannabis use and diabetes to dete ...
MAY 12, 2022
Drug Discovery & Development
Gut Bacteria Composition Predicts Resposnse to Statins
MAY 12, 2022
Gut Bacteria Composition Predicts Resposnse to Statins
The composition of the gut microbiome is predictive of patient responses to statins. The corresponding study was publish ...
MAY 19, 2022
Drug Discovery & Development
Experimental Drug Shows Promise Against ALS
MAY 19, 2022
Experimental Drug Shows Promise Against ALS
A new experimental drug known as NU-9 may be more effective in treating ALS than existing FDA-approved drugs. The corres ...
JUN 14, 2022
Cancer
Maintaining Sample Temperature: Q&A From a Corning Scientist
JUN 14, 2022
Maintaining Sample Temperature: Q&A From a Corning Scientist
Generally speaking, bad things can happen when a cell sample temperature gets too hot or too cold. Temperature instabili ...
JUN 06, 2022
Immunology
Using Antibodies to Create Potent Cancer Treatments
JUN 06, 2022
Using Antibodies to Create Potent Cancer Treatments
Cancer can arise from a variety of aberrations that cause cells to divide uncontrollably, and form a tumor. The causes o ...
Loading Comments...